ASK REDCHAT ANYTHING ABOUT SOLID BIOSCIENCES INC.
Solid Biosciences Inc. (NASDAQ: SLDB)
Listen to this Section
$7.24
+0.3900
(
+5.69% )
451.9K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| SGT-003DetailsGenetic disorder, Duchenne muscular dystrophy |
Phase 1/2 |
| SGT-001 (Microdystrophin Gene Transfer)DetailsGenetic disorder, Muscle weakness, Muscle degeneration |
Failed |
Market Data
| Open |
$7.24 |
| Previous Close |
$6.85 |
| Volume |
451.9K |
| Market Cap |
$674.38M |
| Day Range |
$6.68 - $7.50 |
| 52 Week Range |
$3.41 - $8.87 |
| Shares Outstanding |
98.45M |
| Change % |
+5.69% |
| Net Change |
▲ 0.3900 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
1,297,008.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-05 |
Sale |
-3255.00 |
SMITH IAN F |
| 2024-06-13 |
Sale |
-34400.00 |
Ganot Ilan |
| 2024-06-13 |
Sale |
-34400.00 |
Nagendran Sukumar |
| 2024-06-13 |
Sale |
-34400.00 |
SMITH IAN F |
| 2024-06-13 |
Sale |
-34400.00 |
Sullivan Lynne Marie |
| 2024-06-13 |
Sale |
-34400.00 |
Freed Martin I |
| 2024-06-13 |
Sale |
-34400.00 |
Keresty Georgia |
| 2024-06-13 |
Sale |
-34400.00 |
Kahn Clare |
| 2024-06-11 |
Buy |
1100.00 |
Kahn Clare |
| 2024-05-06 |
Sale |
-1553.00 |
Ganot Ilan |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Nov 13, 2025 |
| 10-q |
Quarterly Reports |
68 |
Nov 03, 2025 |
| 8-k |
8K-related |
64 |
Nov 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 21, 2025 |
| 4 |
Insider transactions |
1 |
Oct 07, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |
| 4 |
Insider transactions |
1 |
Aug 18, 2025 |